Anthony Jaworski

Comparative Incidence of Nephrotoxicity by Age Group among Adult Patients Receiving Vancomycin

Joseph J. Carreno, Anthony Jaworski, Rachel M. Kenney et al. · Infectious Diseases and Therapy · 2013 · 29 citations · Full text

Medicine, Nephrology, Pharmacotherapy +16

INTEGRATE IIa: A randomised, double-blind, phase III study of regorafenib versus placebo in refractory advanced gastro-oesophageal cancer (AGOC)—A study led by the Australasian Gastro-intestinal Trials Group (AGITG).

Nick Pavlakis, Kohei Shitara, Katrin Marie Sjoquist et al. · Journal of Clinical Oncology · 2023 · 29 citations

Medicine, Oncology, Pharmacology +11

INTEGRATE II: randomised phase III controlled trials of regorafenib containing regimens versus standard of care in refractory Advanced Gastro-Oesophageal Cancer (AGOC): a study by the Australasian Gastro-Intestinal Trials Group (AGITG)

Lyn Ley Lam, Nick Pavlakis, Kohei Shitara et al. · BMC Cancer · 2023 · 28 citations · Full text

Medicine, Oncology, Pharmacotherapy +10

INTEGRATE IIa Phase III Study: Regorafenib for Refractory Advanced Gastric Cancer

Nick Pavlakis, Kohei Shitara, Katrin Marie Sjoquist et al. · Journal of Clinical Oncology · 2024 · 20 citations

Medicine, Oncology, Pharmacology +16

Creatine kinase (CK) and creatine kinase isoenzyme (CK-MB) activity in serum before and after intravenous salbutamol administration of patients with bronchial asthma.

R Chazan, W Tadeusiak, Anthony Jaworski et al. · PubMed · 1992 · 10 citations

Medicine, Pharmacology, Pharmacotherapy +9